Literature DB >> 23111637

Roles of Wnt signals in bone resorption during physiological and pathological states.

Kazuhiro Maeda1, Naoyuki Takahashi, Yasuhiro Kobayashi.   

Abstract

Osteoclasts, multinucleated giant cells, are responsible for bone resorption in physiological and pathological conditions such as osteoporosis and rheumatoid arthritis. Osteoclasts develop from the monocyte/macrophage lineage under the strict control of bone-forming osteoblasts. Osteoblast-lineage cells express two cytokines essential for osteoclast differentiation, colony-stimulating factor-1, and receptor activator of nuclear factor κB ligand (RANKL) and also express osteoprotegerin, a soluble decoy receptor for RANKL. The signaling molecule Wnt has been shown to be important for the differentiation of osteoblasts through β-catenin-dependent canonical and β-catenin-independent noncanonical pathways. Recent studies have established that Wnt-mediated signals are also crucial for bone resorption in both physiological and pathological conditions. In this review, we introduce recent advances in roles of Wnt signaling in bone formation and bone resorption.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23111637     DOI: 10.1007/s00109-012-0974-0

Source DB:  PubMed          Journal:  J Mol Med (Berl)        ISSN: 0946-2716            Impact factor:   4.599


  62 in total

1.  Wnt signaling regulates hemopoiesis through stromal cells.

Authors:  T Yamane; T Kunisada; H Tsukamoto; H Yamazaki; H Niwa; S Takada; S I Hayashi
Journal:  J Immunol       Date:  2001-07-15       Impact factor: 5.422

2.  Deletion of a single allele of the Dkk1 gene leads to an increase in bone formation and bone mass.

Authors:  Frederic Morvan; Kim Boulukos; Philippe Clément-Lacroix; Sergio Roman Roman; Isabelle Suc-Royer; Béatrice Vayssière; Patrick Ammann; Patrick Martin; Sonia Pinho; Philippe Pognonec; Patrick Mollat; Christof Niehrs; Roland Baron; Georges Rawadi
Journal:  J Bone Miner Res       Date:  2006-06       Impact factor: 6.741

3.  Canonical Wnt signaling in differentiated osteoblasts controls osteoclast differentiation.

Authors:  Donald A Glass; Peter Bialek; Jong Deok Ahn; Michael Starbuck; Millan S Patel; Hans Clevers; Mark M Taketo; Fanxin Long; Andrew P McMahon; Richard A Lang; Gerard Karsenty
Journal:  Dev Cell       Date:  2005-05       Impact factor: 12.270

Review 4.  Osteoimmunology and the effects of the immune system on bone.

Authors:  Hiroshi Takayanagi
Journal:  Nat Rev Rheumatol       Date:  2009-11-03       Impact factor: 20.543

5.  LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development.

Authors:  Y Gong; R B Slee; N Fukai; G Rawadi; S Roman-Roman; A M Reginato; H Wang; T Cundy; F H Glorieux; D Lev; M Zacharin; K Oexle; J Marcelino; W Suwairi; S Heeger; G Sabatakos; S Apte; W N Adkins; J Allgrove; M Arslan-Kirchner; J A Batch; P Beighton; G C Black; R G Boles; L M Boon; C Borrone; H G Brunner; G F Carle; B Dallapiccola; A De Paepe; B Floege; M L Halfhide; B Hall; R C Hennekam; T Hirose; A Jans; H Jüppner; C A Kim; K Keppler-Noreuil; A Kohlschuetter; D LaCombe; M Lambert; E Lemyre; T Letteboer; L Peltonen; R S Ramesar; M Romanengo; H Somer; E Steichen-Gersdorf; B Steinmann; B Sullivan; A Superti-Furga; W Swoboda; M J van den Boogaard; W Van Hul; M Vikkula; M Votruba; B Zabel; T Garcia; R Baron; B R Olsen; M L Warman
Journal:  Cell       Date:  2001-11-16       Impact factor: 41.582

6.  Bone dysplasia sclerosteosis results from loss of the SOST gene product, a novel cystine knot-containing protein.

Authors:  M E Brunkow; J C Gardner; J Van Ness; B W Paeper; B R Kovacevich; S Proll; J E Skonier; L Zhao; P J Sabo; Y Fu; R S Alisch; L Gillett; T Colbert; P Tacconi; D Galas; H Hamersma; P Beighton; J Mulligan
Journal:  Am J Hum Genet       Date:  2001-02-09       Impact factor: 11.025

7.  Lineage-committed osteoclast precursors circulate in blood and settle down into bone.

Authors:  Akinori Muto; Toshihide Mizoguchi; Nobuyuki Udagawa; Susumu Ito; Ichiro Kawahara; Yoshimitsu Abiko; Atsushi Arai; Suguru Harada; Yasuhiro Kobayashi; Yuko Nakamichi; Josef M Penninger; Toshihide Noguchi; Naoyuki Takahashi
Journal:  J Bone Miner Res       Date:  2011-12       Impact factor: 6.741

8.  Targeted deletion of the sclerostin gene in mice results in increased bone formation and bone strength.

Authors:  Xiaodong Li; Michael S Ominsky; Qing-Tian Niu; Ning Sun; Betsy Daugherty; Diane D'Agostin; Carole Kurahara; Yongming Gao; Jin Cao; Jianhua Gong; Frank Asuncion; Mauricio Barrero; Kelly Warmington; Denise Dwyer; Marina Stolina; Sean Morony; Ildiko Sarosi; Paul J Kostenuik; David L Lacey; W Scott Simonet; Hua Zhu Ke; Chris Paszty
Journal:  J Bone Miner Res       Date:  2008-06       Impact factor: 6.741

9.  Lrp5 functions in bone to regulate bone mass.

Authors:  Yajun Cui; Paul J Niziolek; Bryan T MacDonald; Cassandra R Zylstra; Natalia Alenina; Daniel R Robinson; Zhendong Zhong; Susann Matthes; Christina M Jacobsen; Ronald A Conlon; Robert Brommage; Qingyun Liu; Faika Mseeh; David R Powell; Qi M Yang; Brian Zambrowicz; Han Gerrits; Jan A Gossen; Xi He; Michael Bader; Bart O Williams; Matthew L Warman; Alexander G Robling
Journal:  Nat Med       Date:  2011-05-22       Impact factor: 53.440

10.  Parathyroid hormone (PTH)-induced bone gain is blunted in SOST overexpressing and deficient mice.

Authors:  Ina Kramer; Gabriela G Loots; Anne Studer; Hansjoerg Keller; Michaela Kneissel
Journal:  J Bone Miner Res       Date:  2010-02       Impact factor: 6.741

View more
  33 in total

Review 1.  Osteocyte control of bone remodeling: is sclerostin a key molecular coordinator of the balanced bone resorption-formation cycles?

Authors:  R Sapir-Koren; G Livshits
Journal:  Osteoporos Int       Date:  2014-07-17       Impact factor: 4.507

2.  High dose of TNF-α suppressed osteogenic differentiation of human dental pulp stem cells by activating the Wnt/β-catenin signaling.

Authors:  Zhenjie Qin; Zhixiu Fang; Lei Zhao; Jing Chen; Yuanteng Li; Guangyun Liu
Journal:  J Mol Histol       Date:  2015-06-27       Impact factor: 2.611

3.  Strong effect of SNP rs4988300 of the LRP5 gene on bone phenotype of Caucasian postmenopausal women.

Authors:  Péter Horváth; Bernadett Balla; János P Kósa; Bálint Tóbiás; Balázs Szili; Gyöngyi Kirschner; Gabriella Győri; Karina Kató; Péter Lakatos; István Takács
Journal:  J Bone Miner Metab       Date:  2015-03-12       Impact factor: 2.626

4.  Phospholipase Cγ1 (PLCγ1) Controls Osteoclast Numbers via Colony-stimulating Factor 1 (CSF-1)-dependent Diacylglycerol/β-Catenin/CyclinD1 Pathway.

Authors:  Zhengfeng Yang; Seokho Kim; Sahil Mahajan; Ali Zamani; Roberta Faccio
Journal:  J Biol Chem       Date:  2016-12-09       Impact factor: 5.157

5.  IFT80 is essential for chondrocyte differentiation by regulating Hedgehog and Wnt signaling pathways.

Authors:  Changdong Wang; Xue Yuan; Shuying Yang
Journal:  Exp Cell Res       Date:  2013-01-16       Impact factor: 3.905

6.  Ghrelin Increases Beta-Catenin Level through Protein Kinase A Activation and Regulates OPG Expression in Rat Primary Osteoblasts.

Authors:  Emanuela Mrak; Lavinia Casati; Francesca Pagani; Alessandro Rubinacci; Guido Zarattini; Valeria Sibilia
Journal:  Int J Endocrinol       Date:  2015-03-17       Impact factor: 3.257

7.  Assessment of the Effect of Methotrexate Therapy on Bone Metabolism in Patients with Rheumatoid Arthritis.

Authors:  Jerzy Świerkot; Katarzyna Gruszecka; Agnieszka Matuszewska; Piotr Wiland
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2015-04-03       Impact factor: 4.291

8.  Targeting the giant cell tumor stromal cell: functional characterization and a novel therapeutic strategy.

Authors:  Matthew R Steensma; Wakenda K Tyler; Allison G Shaber; Steven R Goldring; F Patrick Ross; Bart O Williams; John H Healey; P Edward Purdue
Journal:  PLoS One       Date:  2013-07-26       Impact factor: 3.240

9.  Hypercholesterolemia boosts joint destruction in chronic arthritis. An experimental model aggravated by foam macrophage infiltration.

Authors:  I Prieto-Potín; J A Roman-Blas; M J Martínez-Calatrava; R Gómez; R Largo; Gabriel Herrero-Beaumont
Journal:  Arthritis Res Ther       Date:  2013-08-13       Impact factor: 5.156

Review 10.  Sclerostin Antibody Therapy for the Treatment of Osteoporosis: Clinical Prospects and Challenges.

Authors:  Claire MacNabb; D Patton; J S Hayes
Journal:  J Osteoporos       Date:  2016-05-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.